p300 was also found to play a role in a variety of tumours and cell lines, such as prostate cancer, melanoma and various haematological tumours (multiple myeloma cell lines, AML cell lines and non-Hodgkin lymphoma cell lines) [70,133]. Here, EP300 is linked to prostate carcinoma.